CLVT logo

Clarivate Plc Stock Price

NYSE:CLVT Community·US$1.6b Market Cap
  • 4 Narratives written by author
  • 0 Comments on narratives written by author
  • 18 Fair Values set on narratives written by author

CLVT Share Price Performance

US$2.45
2.45 (0.00%)
US$3.64
Fair Value
US$2.45
2.45 (0.00%)
32.2% undervalued intrinsic discount
US$3.61
Fair Value
Price US$2.45
AnalystConsensusTarget US$3.61
yiannisz US$4.21
AnalystLowTarget US$2.40

CLVT Community Narratives

·
Fair Value US$3.64 32.6% undervalued intrinsic discount

Global Pharma And AI Trends Will Build Future Growth

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
Fair Value
·
Fair Value US$4.21 41.8% undervalued intrinsic discount

Clarivate Stock: When Data Becomes the Backbone of Innovation and Law

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
·
Fair Value US$2.4 2.1% overvalued intrinsic discount

Rising Regulatory Costs And Data Erosion Will Undermine Future Performance

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
US$4.21
41.8% undervalued intrinsic discount
Fair Value
Profit Margin
8.66%
Future PE
17.81x
Price in 2030
US$7.33

Trending Discussion

Updated Narratives

CLVT logo

Clarivate Stock: When Data Becomes the Backbone of Innovation and Law

Fair Value: US$4.21 41.8% undervalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CLVT logo

CLVT: Free Cash Flow May Offset AI And Portfolio Execution Risks

Fair Value: US$3.64 32.6% undervalued intrinsic discount
4 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CLVT logo

CLVT: Life Sciences Sale Execution Will Drive Upside Despite AI Risk

Fair Value: US$6 59.2% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with moderate growth potential.

0 Risks
4 Rewards

Clarivate Plc Key Details

US$2.4b

Revenue

US$818.7m

Cost of Revenue

US$1.6b

Gross Profit

US$1.8b

Other Expenses

-US$137.4m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.21
66.54%
-5.62%
88.9%
View Full Analysis

About CLVT

Founded
1864
Employees
12000
CEO
Matitiahu Shem Tov
WebsiteView website
www.clarivate.com

Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinary curated content, such as databases, dissertations, news, primary sources, books, and video formats; library software, including Alma, library services platform; and Vega and Polaris for public libraries. It also provides patent maintenance and administrative services; Derwent Innovation, an AI-powered search; Derwent World Patents Index to identify related concepts in patent publications and navigate new or unfamiliar technology categories; CompuMark, a trademark search and watch solutions; IP Recordals managed services; and RiskMark, an AI-powered tool for evaluating trademark risk and argument drafting support. In addition, the company offers IPfolio, a management platform; FoundationIP solution for law firms; Cortellis for decisions related to assessing the market, analyzing competitors, regulatory compliance, and drug safety; Regulatory Intelligence platform; commercial solutions; and Medtech solutions. It serves academic institutions, government agencies, and life sciences, and pharmaceutical companies. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

Recent CLVT News & Updates

Seeking Alpha May 13

Clarivate: Business Showed Signs Of Stabilization, But It Is Not Enough

Summary Clarivate delivered improved Q1 2026 results, with organic growth turning positive at 0.6% and margin expansion, but reported revenue still declined year over year. Segment trends stabilized, notably with Academia & Government and Life Sciences & Healthcare returning to growth, though IPPG remained a drag at -1.3% organic growth. AI-driven product enhancements and the Value Creation Plan could accelerate organic growth, but sustained improvement is needed before a re-rating is justified. I maintain a hold rating, seeking several more quarters of cleaner execution and stronger IPPG performance before turning more constructive. Read the full article on Seeking Alpha
Narrative Update May 06

CLVT: Life Sciences Sale Execution Will Drive Upside Despite AI Risk

Analysts have trimmed their price expectations for Clarivate, with new targets ranging roughly from $2.40 to $6.00. They cited concerns around AI-related disruption risks and execution on the planned Life Sciences and Healthcare asset sale.

Recent updates

No updates